Quick-Relief nasal spray combo tested for kids with stubborn allergies
NCT ID NCT07593898
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether adding a decongestant nasal spray for the first 5 days to standard steroid spray treatment helps children with persistent allergic rhinitis feel better faster. 76 children aged 4-18 were randomly assigned to receive either steroid spray alone for 4 weeks or steroid spray plus the decongestant for the first 5 days. The researchers measured changes in nasal symptoms, airflow, and quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Mometasone furoate nasal spray and oxymetazoline nasal spray
- What this could lead to
- If successful, this approach could offer quicker symptom relief for children with persistent allergies, improving their quality of life and treatment adherence.
- What could go wrong
- This is a small, completed Phase 4 trial with only 76 children. The decongestant is only used for 5 days, and long-term benefits or risks are not assessed. Results may not apply to all children.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERSISTENT ALLERGIC RHINITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dr. Behcet Uz Pediatric Diseases and Surgery Training and Research Hospital
Izmir, 35180, Turkey (Türkiye)